Adherence to Tuberculosis Therapy among Patients Receiving Home-Based Directly Observed Treatment: Evidence from the United Republic of Tanzania

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Mkopi, Abdallah ^a   Range, Nyagosya ^b   Lwilla, Fred ^a   Egwaga, Saidi ^c   Schulze, Alexander ^d   Geubbels, Eveline ^a   van Leth, Frank ^e,f  

^a IFAKARA HEALTH INSTITUTE   (Tanzania)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (Tanzania)

^c MINISTRY OF HEALTH AND SOCIAL WELFARE   (Tanzania)

^d NOVARTIS PHARMA AG   (Switzerland)

^e KNCV TUBERCULOSIS FOUNDATION   (Netherlands)

^f UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; TUBERCULOSTATIC AGENT;

ADULT; AGE DISTRIBUTION; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG DETERMINATION; FEMALE; HOME CARE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT CENTERED TREATMENT; PATIENT COMPLIANCE; RISK FACTOR; SEX DIFFERENCE; TANZANIA; TREATMENT FAILURE; TUBERCULOSIS; URINALYSIS;

ADOLESCENT; ADULT; ANTITUBERCULAR AGENTS; CROSS-SECTIONAL STUDIES; DIRECTLY OBSERVED THERAPY; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PATIENT COMPLIANCE; SELF ADMINISTRATION; TANZANIA; TREATMENT OUTCOME; TUBERCULOSIS; YOUNG ADULT;

MYCOBACTERIUM TUBERCULOSIS;

EID: 84871289081     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0051828     Document Type: Article

References (37)

1. Johnson JL, Okwera A, Vjecha MJ, Byekwaso F, Nakibali J, et al. (1997) Risk factors for relapse in human immunodeficiency virus type 1 infected adults with pulmonary tuberculosis. Int J Tuberc Lung Dis 1: 446-453.
2. El-Sadr WM, Perlman DC, Denning E, Matts JP, Cohn DL, (2001) A review of efficacy studies of 6-month short-course therapy for tuberculosis among patients infected with human immunodeficiency virus: differences in study outcomes. Clin Infect Dis 32: 623-632.
3. WHO (2002) An Expanded DOTS Framework for Effective Tuberculosis Control. World Health Organisation, Geneva, Switzerland. Available: http://whqlibdoc.who.int/hq/2002/WHO_CDS_TB_2002.297.pdf. Accessed 6 June 2012.
4. Egwaga S, Mkopi A, Range N, Haag-Arbenz V, Baraka A, et al. (2009) Patient-centred tuberculosis treatment delivery under programmatic conditions in Tanzania: a cohort study. BMC Med 7: 80.
5. Ministry of Health (2011) National Tuberculosis And Leprosy Programme Annual Report 2010. MOH, Dar es Salaam, Tanzania.
6. Churchyard GJ, Corbett EL, Kleinschmidt I, Mulder D, De Cock KM, (2000) Drug-resistant tuberculosis in South African gold miners: incidence and associated factors. Int J Tuberc Lung Dis 4: 433-440.
7. Werb D, Mills EJ, Montaner JS, Wood E, (2010) Risk of resistance to highly active antiretroviral therapy among HIV-positive injecting drug users: a meta-analysis. Lancet Infect Dis 10: 464-469.
8. Uzochukwu BS, Onwujekwe OE, Onoka AC, Okoli C, Uguru NP, et al. (2009) Determinants of non-adherence to subsidized anti-retroviral treatment in southeast Nigeria. Health Policy Plan 24: 189-196.
9. van den Boogaard J, Boeree MJ, Kibiki GS, Aarnoutse RE, (2011) The complexity of the adherence-response relationship in tuberculosis treatment: why are we still in the dark and how can we get out? Trop Med Int Health 16: 693-698.
10. Kaiser RM, Schmader KE, Pieper CF, Lindblad CI, Ruby CM, et al. (2006) Therapeutic failure-related hospitalisations in the frail elderly. Drugs Aging 23: 579-586.
11. Chonde TM, Basra D, Mfinanga SG, Range N, Lwilla F, et al. (2010) National anti-tuberculosis drug resistance study in Tanzania. Int J Tuberc Lung Dis 14 (8):: 967-72.
12. Chum HJ, Ilmolelian G, Rieder HL, Msangi J, Mwinyi N, et al. (1995) Impact of the change from an injectable to a fully oral regimen on patient adherence to ambulatory tuberculosis treatment in Dar es Salaam, Tanzania. Tuber Lung Dis 76: 286-289.
13. Lwilla F, Schellenberg D, Masanja H, Acosta C, Galindo C, et al. (2003) Evaluation of efficacy of community based versus institutional based direct observed short course treatment for the control of tuberculosis in Kilombero district, Tanzania. Trop.Med Int Health 8 (3):: 203-210.
14. Wagner JH, Justice AC, Chesney M, Sinclair G, Weissman S, et al. (2001) Patient and provider reported adherence, toward a clinically useful approach to measuring antiretroviral adherence. J Clin Epidemiol 54 (Supp 1):: S91-S98.
15. Horizons/Population Council (2004) Adherence to Antiretroviral Therapy in Adults: A Guide for Trainers Nairobi. Population Council, International Centre for Reproductive Health, Coast Province General Hospital, Mombasa. Nairobi, Kenya. Available: http://www.popcouncil.org/pdfs/horizons/arvadhrnctrngguide.pdf. Accessed 6 June 2012.
16. van den Boogaard J, Lyimo RA, Boeree MJ, Kibiki GS, Aarnoutse RE, (2011) Electronic monitoring of treatment adherence and validation of alternative adherence measures in tuberculosis patients: a pilot study. Bull World Health Organ 89: 632-639.
17. National Bureau of Statistics Dar es Salaam, Tanzania: ICF Macro, Calverton, Maryland, USA (2011) Tanzania Demographic and Health Survey 2010. Available: http://www.measuredhs.com/pubs/pdf/FR243/FR24324June2011.pdf. Accessed 6 June 2012.
18. Munro SA, Lewin SA, Smith HJ, Engel ME, Fretheim A, et al. (2007) Patient adherence to tuberculosis treatment: a systematic review of qualitative research. PLoS Med 4: e238.
19. IsoScreen (2010) GFC Diagnostics Ltd, Bicester, Oxon, UK. Available: http://www.gfcdiagnostics.co.uk. Accessed 6 June 2012.
20. Guerra RL, Conde MB, Efron A, Loredo C, Bastos G, et al. (2010) Point-of-care Arkansas method for measuring adherence to treatment with isoniazid. Respir Med 104: 754-757.
21. Amuha MG, Kutyabami P, Kitutu FE, Odoi-Adome R, Kalyango JN, (2009) Non-adherence to anti-TB drugs among TB/HIV co-infected patients in Mbarara Hospital Uganda: prevalence and associated factors. Afr Health Sci 9 (Suppl 1):: S8-S15.
22. Mqoqi NP, Churchyard GA, Kleinschmidt I, Williams B, (1997) Attendance versus compliance with tuberculosis treatment in an occupational setting-a pilot study. S Afr Med J 87: 1517-1521.
23. Kebede A, Wabe NT, (2012) Medication adherence and its determinants among patients on concomitant tuberculosis and antiretroviral therapy in South west ethiopia. N Am J Med Sci 4: 67-71.
24. Amuha MG, Kutyabami P, Kitutu FE, Odoi-Adome R, Kalyango JN, (2009) Non-adherence to anti-TB drugs among TB/HIV co-infected patients in Mbarara Hospital Uganda: Prevalence and associated factors. Afr Health Sci 9: S8-S15.
25. Franks J, Hirsch-Moverman Y, Colson P (2005) Adherence to Treatment for Latent Tuberculosis Infection: A Manual for Health Care Providers. Charles P Felton National Tuberculosis Center: New York, USA. Available: http://www.harlemtbcenter.org/Assets/web_docs/Harlem-LTBI%20Adherence6.pdf. Accessed 6 June 2012.
26. Girma A, Mariam D, Deribe K, (2010) Quality of tuberculosis care in six health facilities of Afar Region, Ethiopia. Ethiop Med J 48: 195-202.
27. Zvavamwe Z, Ehlers VJ, (2009) Experiences of a community-based tuberculosis treatment programme in Namibia: a comparative cohort study. Int J Nurs Stud 46: 302-309.
28. Olayemi SO, Oreagba IA, Akinyede A, Adepoju GE, (2009) Educational intervention and the health seeking attitude and adherence to therapy by tuberculosis patients from an urban slum in lagos Nigeria. Niger Postgrad Med J 16: 231-235.
29. Jaiswal A, Singh V, Ogden JA, Porter JD, Sharma PP, et al. (2003) Adherence to tuberculosis treatment: lessons from the urban setting of Delhi, India. Trop Med Int Health 8: 625-633.
30. Khan MA, Walley JD, Witter SN, Shah SK, Javeed S, (2005) Tuberculosis patient adherence to direct observation: results of a social study in Pakistan. Health Policy Plan 20: 354-365.
31. Garner P, Volmink J, (2006) Families help cure tuberculosis. Lancet 367: 878-879.
32. Newell JN, Baral SC, Pande SB, Bam DS, Malla P, (2006) Family-member DOTS and community DOTS for tuberculosis control in Nepal: cluster-randomised controlled trial. Lancet 367: 903-909.
33. Getahun H, (1999) Medical and social consequences of tuberculosis in rural Ethiopia. Ethiop Med J 37: 147-153.
34. Centers for Disease Control and Prevention (CDC) (2006) HIV counseling, testing, and care of tuberculosis patients at chest clinics-Guyana, 2005-2006. MMWR Morb Mortal Wkly Rep 55: 849-851.
35. Peltzer K, Mngqundaniso N, Petros G, (2006) A controlled study of an HIV/AIDS/STI/TB intervention with traditional healers in KwaZulu-Natal, South Africa. AIDS Behav 10: 683-690.
36. Chimzizi RB, Harries AD, Manda E, Khonyongwa A, Salaniponi FM, (2004) Counselling, HIV testing and adjunctive cotrimoxazole for TB patients in Malawi: from research to routine implementation. Int J Tuberc Lung Dis 8: 938-944.
37. Okanurak K, Kitayaporn D, Akarasewi P, (2008) Factors contributing to treatment success among tuberculosis patients: a prospective cohort study in Bangkok. Int J Tuberc Lung Dis 12: 1160-1165.